跳至主要内容
临床试验/IRCT201406299014N37
IRCT201406299014N37Other2 期

The effect of hydroxychloroquine versus standard drug therapy on the treatment and recurrence of brucellosis: a single blinded randomized clinical trial

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences0 个研究点目标入组 176 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
Other
发起方
入组人数
176

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • (a) patients with sign and symptoms of brucellosis have Wright test of more than 1/160 and 2ME titer more than 1/80; (b) patients with chronic brucellosis who did not responded to standard drug therapy with constant or increased 2ME titer; (c) age of 18 years or older.
  • Exclusion criteria: (a) being pregnant; (b) having history of porphyria, psoriasis, degenerative macula, hemolytic diseases, gastrointestinal diseases, neurologic diseases, and G6PD deficiency.

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences

相似试验